Hormosan Pharma GmbH

About Hormosan Pharma GmbH

Hormosan was founded in Germany over 50 years ago and has since developed successfully into a mid-sized pharmaceutical company. Today we market a large portfolio spanning from innovative medicines to generics, focusing on three core therapeutic areas: rare diseases in neurology, pain therapy for chronic pain and headaches, and sexual health with a focus on oral contraceptives, erectile dysfunction, and HIV. With our innovative medicines, we address hitherto unmet needs of our patients. Specific formulations or dosage forms of our specialty-like medications enhance patient benefits and compliance. And with our generics, we provide high-quality therapeutic options with attractive pricing. In 2008, Hormosan was acquired by the international pharmaceutical LUPIN Group. Being embedded in this global network also continuously drives our competitiveness, which is the foundation for us to provide long-term attractive therapeutic options to patients in the German market.